Atlas Trials

Omic Technologies to Track Resistance to Palbociclib in Metastatic Breast Cancer

Clinical trial NCT04653740 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04653740
Sponsor
Centre Oscar Lambret
Status
ACTIVE_NOT_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Advanced Breast Cancer
Start date
2020-09-08
Primary completion
2026-06-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.